Showing 1 - 6 results of 6 for search 'Zheng-Jun Zhou', query time: 0.05s Refine Results
  1. 1
    Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection

    Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection by Zhi-Qiang Hu, Zheng-Jun Zhou, Chu-Bin Luo, Hao-Yang Xin, Jia Li, Song-Yang Yu, Shao-Lai Zhou

    Published 2020-12-01
    Get full text
    Article
  2. 2
    LINC01133 promotes hepatocellular carcinoma progression by sponging miR‐199a‐5p and activating annexin A2

    LINC01133 promotes hepatocellular carcinoma progression by sponging miR‐199a‐5p and activating annexin A2 by Dan Yin, Zhi‐Qiang Hu, Chu‐Bin Luo, Xiao‐Yi Wang, Hao‐Yang Xin, Rong‐Qi Sun, Peng‐Cheng Wang, Jia Li, Jia Fan, Zheng‐Jun Zhou, Jian Zhou, Shao‐Lai Zhou

    Published 2021-05-01
    Get full text
    Article
  3. 3
    Correction: MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET–SOCS1–MMP9 signaling axis

    Correction: MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET–SOCS1–MMP9 signaling axis by Qing Chen, Dan Yin, Yong Zhang, Lei Yu, Xue-Dong Li, Zheng-Jun Zhou, Shao-Lai Zhou, Dong-Mei Gao, Jie Hu, Cheng Jin, Zheng Wang, Ying-Hong Shi, Ya Cao, Jia Fan, Zhi Dai, Jian Zhou

    Published 2024-11-01
    Get full text
    Article
  4. 4
    Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver

    Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver by Zheng-Jun Zhou, Yu-Hang Ye, Zhi-Qiang Hu, Yue-Ru Hou, Kai-Xuan Liu, Rong-Qi Sun, Peng-Cheng Wang, Chu-Bin Luo, Jia Li, Ji-Xue Zou, Jian Zhou, Jia Fan, Cheng-Li Song, Shao-Lai Zhou

    Published 2024-11-01
    Get full text
    Article
  5. 5
    Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma

    Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma by Yu-Hang Ye, Hao-Yang Xin, Jia-Li Li, Ning Li, Si-Yuan Pan, Long Chen, Jing-Yue Pan, Zhi-Qiang Hu, Peng-Cheng Wang, Chu-Bin Luo, Rong-Qi Sun, Jia Fan, Jian Zhou, Zheng-Jun Zhou, Shao-Lai Zhou

    Published 2024-10-01
    Get full text
    Article
  6. 6
    Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular CarcinomaSummary

    Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular CarcinomaSummary by Gui-Qi Zhu, Yi Wang, Biao Wang, Wei-Ren Liu, Shuang-Shuang Dong, Er-Bao Chen, Jia-Liang Cai, Jing-Lei Wan, Jun-Xian Du, Li-Na Song, Shi-Ping Chen, Lei Yu, Zheng-Jun Zhou, Zheng Wang, Jian Zhou, Ying-Hong Shi, Jia Fan, Zhi Dai

    Published 2022-01-01
    Get full text
    Article

Search Tools: